Dr. Paul Richardson of @danafarber.bsky.social presents results from SUCCESSOR-2 study showing the oral drug mezigdomide markedly improved PFS in patients w/relapsed or refractory multiple myeloma. Results support this novel therapy as a possible new standard of care for RRMM. #ASCO26 bit.ly/4wUzw6z
ICYMI: “I could not be more appreciative and more grateful to the incredible team at Dana-Farber,” Boston Firefighters IAFF Local 718 President Sam Dillon told @bostonglobe.com regarding @danafarber.bsky.social’s pledge to help fund @boston.gov’s firefighter cancer screening program. bit.ly/3Rv7DSI
Dr. Hal Burstein of @danafarber.bsky.social spoke with @nbcnews.com about male breast cancer following Tyler Mane’s announcement that he has been diagnosed with this rare but highly treatable disease. ➡️bit.ly/4eEv5pt
Featured on @boston25news.com: Work has begun on @danafarber.bsky.social new 300-bed inpatient facility expected to open in 2031. It will be the region’s only hospital dedicated exclusively to adult cancer care.
▶️bit.ly/42X2QMf
ICYMI: Featured on @wbztv.bsky.social: @danafarber.bsky.social and @boston.gov announce funding to help preserve access to comprehensive early cancer screenings for Boston firefighters who are often exposed to carcinogens and toxic smoke in the line of duty. ➡️ bit.ly/4tTFCBL
Marilyn Hammer, PhD, DC, RN, FAAN, director of @danafarber.bsky.social’s Cantor Center for Research, tells Oncology Nursing News how its mission over 25 yrs expanded to precision health symptom science & health equity while bridging the gap between academic research/clinical bedside. bit.ly/4vN5656
Congratulations to @danafarber.bsky.social’s Ann Partridge, MD, MPH, who is the recipient of @gohealio.bsky.social’s 2026 Lifetime Disruptor Award in recognition of her outstanding and ongoing contributions to the field of breast cancer research and treatment.
In People magazine: From his hospital bed, Robbie Fox and Kelli Peters, both 27, said “I do” just 10 days before he succumbed to Ewing sarcoma. The couple got engaged in March 2025, after Fox went into remission following treatment at @danafarber.bsky.social. ➡️bit.ly/4uUTwoz
New research by @danafarber.bsky.social’s Dr. Suzanne George in JNCI Cancer Spectrum describes the user-centered development and pilot implementation of the Participant Engagement Portal (PEP) by @alliance-org.bsky.social to improve information flow. Read more: bit.ly/43w3Res
“We’ve demonstrated that we can successfully run trials for adolescents & young adults with sarcomas, and we're excited to have a growing portfolio of drugs and clinical trials for these diseases,” says @danafarber.bsky.social’s Dr. David Shulman. @dfciayasarcoma.bsky.social ➡️bit.ly/3RWIq3O
The donation will enable 500 firefighters to undergo full-body CT scans in the coming fiscal year.
Robbie Fox and Kelli Peters married in a hospital ceremony on April 15, just 10 days before his death following an Ewing Sarcoma diagnosis.
bit.ly
Published: June 8, 2026Sarcomas are cancers that occur in bone or soft tissue, such as muscles and fat. These cancers are rare and diverse, with more than 150 different variations. Treatment is advancing for some sarcomas, but most forms of the disease are still treated using chemotherapy, radiation and/or surgery. In some cases, there are few options if the cancer comes back. Dana-Farber physician-scientists are evaluating innovative ... Read more
Talk of breast cancer is often “shrouded in pink,” one expert said, which can lead to less awareness among men about potential risk factors and symptoms.
bit.ly
AbstractBackground. Digital tools may enhance clinical trial engagement by improving information flow and supporting participant-directed communication. Th
